The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population

Derek Ebnera Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]

John Kisiela Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

Lianne Barniehb Maple Health Group, New York, NY, USA

Rishika Sharmab Maple Health Group, New York, NY, USA

Nathaniel J. Smithb Maple Health Group, New York, NY, USA

Chris Estesc Exact Sciences, Madison, WI, USA

Vahab Vahdatc Exact Sciences, Madison, WI, USA

A. Burak Ozbayc Exact Sciences, Madison, WI, USA

Paul Limburgc Exact Sciences, Madison, WI, USA

A. Mark Fendrickd Center for Value Based Insurance Design, University of Michigan, Ann Arbor, MI, USA

Your download is now in progress and you may close this window